CEL-SCI: Funding, Investors & Team (Sep 2026)
CEL-SCI Corporation is a biotechnology company. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. The Company's core capabilities include: drug discovery, research, development and manufacturing of complex biological substances.
CEL-SCI has raised $9.7M across 2 funding rounds on record, the most recent an undisclosed round of $2.5M announced in Jun 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CEL-SCI Company Profile and Key Stats
Latest funding round on record: Jun 2026.
CEL-SCI Funding Rounds
CEL-SCI raised $7.2M in an undisclosed round announced in May 2026.
1 month later, an undisclosed round of $2.5M was announced in Jun 2026.
CEL-SCI Founders and Leadership Team
Contact details for the CEL-SCI team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →CEL-SCI Funding Compared to Other Biotechnology Startups
CEL-SCI's latest round of $2.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CEL-SCI in Biotechnology and Vienna
Companies Similar to CEL-SCI
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
CEL-SCI Funding FAQs
What does CEL-SCI do?
CEL-SCI Corporation is a biotechnology company. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. The Company's core capabilities include: drug discovery, research, development and manufacturing of complex biological substances.
How much funding has CEL-SCI raised?
CEL-SCI has raised $9.7M across 2 rounds on record. The most recent is an undisclosed round of $2.5M announced in Jun 2026.
When did CEL-SCI last raise funding?
CEL-SCI's most recent funding round on record is an undisclosed round of $2.5M, announced in Jun 2026.
Who founded CEL-SCI?
FundedIQ lists Eyal Talor (Founder), Robert (bob) (Founder) at CEL-SCI.
Where is CEL-SCI headquartered?
CEL-SCI is based in Vienna, Virginia, United States.
How many employees does CEL-SCI have?
CEL-SCI is in the 11-50 employee band.
How does CEL-SCI's funding compare to other Biotechnology startups?
CEL-SCI's latest round of $2.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's CEL-SCI Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CEL-SCI is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.